☰

Aparna Chhibber - Publications

Affiliations: 
2014 Pharmaceutical Sciences and Pharmacogenomics University of California, San Francisco, San Francisco, CA 
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Luo L, Shen J, Zhang H, Chhibber A, Mehrotra DV, Tang ZZ. Multi-trait analysis of rare-variant association summary statistics using MTAR. Nature Communications. 11: 2850. PMID 32503972 DOI: 10.1038/s41467-020-16591-0  0.316
2017 Eclov RJ, Kim MJ, Chhibber A, Smith RP, Ahituv N, Kroetz DL. ABCG2 regulatory single-nucleotide polymorphisms alter in-vivo enhancer activity and expression. Pharmacogenetics and Genomics. PMID 28930109 DOI: 10.1097/Fpc.0000000000000312  0.568
2016 Chhibber A, French CE, Yee SW, Gamazon ER, Theusch E, Qin X, Webb A, Papp AC, Wang A, Simmons CQ, Konkashbaev A, Chaudhry AS, Mitchel K, Stryke D, Ferrin TE, et al. Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines. The Pharmacogenomics Journal. PMID 26856248 DOI: 10.1038/Tpj.2015.93  0.557
2015 Haenisch S, Zhao Y, Chhibber A, Kaiboriboon K, Do LV, Vogelgesang S, Barbaro NM, Alldredge BK, Lowenstein DH, Cascorbi I, Kroetz DL. SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients. Neurobiology of Disease. 77: 127-40. PMID 25766675 DOI: 10.1016/J.Nbd.2015.02.025  0.529
2014 Chhibber A, Kroetz DL, Tantisira KG, McGeachie M, Cheng C, Plenge R, Stahl E, Sadee W, Ritchie MD, Pendergrass SA. Genomic architecture of pharmacological efficacy and adverse events. Pharmacogenomics. 15: 2025-48. PMID 25521360 DOI: 10.2217/Pgs.14.144  0.62
2014 Chhibber A, Mefford J, Stahl EA, Pendergrass SA, Baldwin RM, Owzar K, Li M, Winer EP, Hudis CA, Zembutsu H, Kubo M, Nakamura Y, McLeod HL, Ratain MJ, Shulman LN, et al. Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). The Pharmacogenomics Journal. 14: 336-42. PMID 24513692 DOI: 10.1038/Tpj.2014.2  0.587
2014 Chhibber A, Micheli J, Kroetz DL. Polymorphisms of Drug Transporters and Clinical Relevance Drug Transporters: Molecular Characterization and Role in Drug Disposition: Second Edition. 389-407. DOI: 10.1002/9781118705308.ch20  0.5
2013 Haenisch S, Chhibber A, Cascorbi I, Kroetz D. PP123—Target gene evaluation of two mirnas differently expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients Clinical Therapeutics. 35: e53-e54. DOI: 10.1016/J.Clinthera.2013.07.146  0.535
2012 Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, et al. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5099-109. PMID 22843789 DOI: 10.1158/1078-0432.Ccr-12-1590  0.572
Show low-probability matches.